Diligence memo · auto-generated · as of July 2, 2026
Ortho-tag, Inc.
Ortho-tag, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Ortho-tag, Inc. operates in Biotechnology, based in PITTSBURGH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ortho-tag, Inc. has raised $1.6M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.6M on 2011-08-15.
Most recent recorded round closed around 2011-08-15.
Valuation (modeled)modeled
Provath models Ortho-tag, Inc. at approximately $71M (range $1.2M–$557M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.82× the median modeled value of Seed Biotechnology companies in 2010–2012 (151 peers) — value vs value, same stage and era. Within the normal band (82% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 14.9 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 25% of Biotechnology peers (4293 compared).
Modeled value ranks above 52% of those peers.
Closest niche peers: Denali Medical II, Inc., Signum Biosciences, Inc., Health Elements, LLC, Nkt Therapeutics Inc, Surface Logix Inc.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.